Kentucky 2022 Regular Session

Kentucky House Bill HB219

Introduced
1/5/22  
Refer
1/5/22  
Refer
1/19/22  
Report Pass
1/20/22  
Engrossed
1/27/22  
Refer
1/27/22  
Refer
1/31/22  
Report Pass
3/16/22  
Refer
3/22/22  
Enrolled
3/29/22  
Enrolled
3/29/22  
Chaptered
3/31/22  

Caption

AN ACT relating to lung cancer screening.

Impact

The bill introduces significant changes to public health policy in Kentucky by creating a comprehensive framework aimed at enhancing lung cancer screening initiatives. It establishes a restricted funding source to support the program, which will be managed by the Department for Public Health. The funding will come from state appropriations and the revenues generated from specialized lung cancer license plates. This financial mechanism ensures that resources are allocated specifically for lung cancer screening efforts, aiming for sustainability in public health endeavors.

Summary

House Bill 219, also known as the Margaret M. Poore Lung Cancer Screening Act, aims to establish a structured Lung Cancer Screening Program in Kentucky. The primary objectives of this legislation are to increase lung cancer screenings, thereby reducing the incidence of morbidity and mortality associated with the disease, as well as to decrease the costs related to treating lung cancer for residents of the Commonwealth. The bill emphasizes the importance of early detection and intervention to improve health outcomes for individuals at risk of lung cancer.

Sentiment

The sentiment surrounding HB 219 is largely positive, particularly among public health advocates and cancer prevention organizations. The establishment of a dedicated lung cancer screening program is viewed as a proactive measure addressing a crucial health issue. Supporters see this bill as a vital step toward reducing health disparities, particularly in communities disproportionately affected by lung cancer. However, there may be concerns regarding the effectiveness and implementation of the program, requiring ongoing dialogue among stakeholders to address any potential challenges.

Contention

As the bill progresses, some points of contention may arise, particularly related to the governance of the Lung Cancer Screening Advisory Committee, which is tasked with overseeing the program's implementation. The composition of the committee, including representatives from various health organizations and government officials, is designed to incorporate a range of expertise. Opposing views may focus on issues related to funding allocation, transparency in program operations, and the evaluation of the screening outcomes. These discussions will be essential to ensure the program meets its intended goals while addressing the diverse needs of Kentucky residents.

Companion Bills

No companion bills found.

Previously Filed As

KY HB421

AN ACT relating to colorectal cancer screenings.

KY HB1316

To Mandate Coverage For Lung Cancer Screenings.

KY HB443

AN ACT relating to coverage for parental and guardian depression screenings.

KY HB269

AN ACT relating to coverage for parental and guardian depression screenings.

KY HB406

AN ACT relating to coverage for perinatal mood and anxiety disorders screenings.

KY HB627

AN ACT relating to coverage for perinatal mood and anxiety disorders screenings.

KY HB387

AN ACT relating to reorganization.

KY HB3726

IDPH-LUNG CANCER SCREENING

KY SB105

AN ACT relating to newborn and infant screenings.

KY HB374

AN ACT relating to newborn and infant screenings.

Similar Bills

No similar bills found.